Results 181 to 190 of about 7,868,209 (310)

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, EarlyView.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

Arthritis Care &Research, EarlyView.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall, Cinthia Blat, Eric Roberts, Jean W. Liew, Katherine Wysham, Namrata Singh, Janna Friedly, Lianne S. Gensler, Gabriela Schmajuk, Jinoos Yazdany   +9 more
wiley   +1 more source

Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence. [PDF]

Endocrinol Diabetes Metab
Acucella GA, Caponio D.
europepmc   +1 more source

Review of the existing maximum residue levels (MRLs) for 2,4‐DB according to Article 12 of Regulation (EC) No 396/2005

EFSA Journal, 2011
European Food Safety Authority
doaj   +1 more source

Retractions in Rheumatology: Trends, Causes, and Implications for Research Integrity

Arthritis Care &Research, EarlyView.
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley   +1 more source

Determinants, patterns, and gaps in patient safety and quality of care research in Israel: a scoping review. [PDF]

Isr J Health Policy Res
Ben Natan M.
europepmc   +1 more source

Review of the existing maximum residue levels (MRLs) for clodinafop according to Article 12 of Regulation (EC) No 396/2005

EFSA Journal, 2011
European Food Safety Authority
doaj   +1 more source

Effect of Implementing a Dashboard With or Without a Best Practice Alert on HLA‐B*58:01 Testing Rates Among Allopurinol Users at VA Medical Centers

Arthritis Care &Research, EarlyView.
Objective The American College of Rheumatology recommends HLA‐B*58:01 allele testing before the initiation of allopurinol, specifically among Asian and African American/Black patients, due to their increased risk for severe hypersensitivity reactions. However, testing rates remain low at many health care facilities.
Abimbola Fadairo‐Azinge, Gabriela Schmajuk, Sristi Sharma, Colleen P. Flanagan, Sara Faghihi‐Kashani, Ning Zhang, Mary A. Whooley   +6 more
wiley   +1 more source

Nursing work environment and moral sensitivity as factors influencing nurses' safety behaviors: the mediating role of professional identity. [PDF]

Front Public Health
Liu S, Li X, Lin T, Gao X, Ai M.
europepmc   +1 more source

Assessment of the feed additive consisting of coated granulated calcium iodate anhydrous for all animal species for the renewal of its authorisation (DOX-AL ITALIA SPA). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Aquilina G, Gropp J, Galobart J, Holczknecht O, Navarro-Villa A, Pizzo F, Tarrés-Call J, Vettori MV, Gkimprixi E.   +24 more
europepmc   +1 more source